| 5/16/2013 | | ACT Confirms Clinical Trial Participant Showed Improvement in Vision from 20/400 to 20/40 Following Treatment |
|
| 5/10/2013 | | Advanced Cell Technology Announces 2013 First Quarter Results |
|
| 5/6/2013 | | Advanced Cell Technology to Host Conference Call to Discuss 2013 First Quarter Results and Provide a Corporate Update on Thursday, May 9th |
|
| 4/23/2013 | | ACT Initiates Higher-Dosage Patient Treatment in European Clinical Trial for Macular Degeneration |
|
| 4/16/2013 | | Advanced Cell Technology to Present at Regen Med Investor Day 2013 |
|
| 4/15/2013 | | ACT Treats First Patient with Better Vision in Clinical Trial for Stargardt's Macular Dystrophy |
|
| 4/1/2013 | | ACT Initiates Treatment of Higher-Dosage Cohort in Clinical Trials for Dry Age-Related Macular Degeneration and Stargardt's Macular Dystrophy |
|
| 3/22/2013 | | ACT’s Chief Scientific Officer Dr. Robert Lanza to Deliver the Nerem Lecture 2013 at the 17th Annual Hilton Head Workshop |
|
| 3/14/2013 | | Advanced Cell Technology Receives Approval from Data Safety Monitoring Board (DSMB) to Initiate Treatment of Third Patient Cohort in All Three Clinical Trials |
|
| 3/12/2013 | | ACT’s Dr. Robert Lanza Voted Top 4 “Most Influential People on Stem Cells” |
|
| 3/8/2013 | | Advanced Cell Technology to Present at BIO-Europe Spring 2013 |
|
| 3/7/2013 | | Advanced Cell Technology Announces Fourth-Quarter and Year-end Results |
|
| 3/4/2013 | | Advanced Cell Technology to Announce Fourth Quarter and Year-end Results on Thursday March 7th |
|
| 2/11/2013 | | ACT’s Chief Scientific Officer Robert Lanza, MD, Appointed Editor-in-Chief of BioResearch Open Access Journal |
|
| 2/11/2013 | | ACT’s Clinical Partner Receives FDA Approval to Initiate Clinical Trial Using the Company’s hESC-derived Cells to Treat Severe Myopia |
|
| 2/8/2013 | | Advanced Cell Technology to Present at 15th Annual BIO CEO & Investor Conference |
|
| 1/22/2013 | | Patients with Better Vision to be Enrolled in ACT's Clinical Trials for Macular Degeneration |
|
| 1/17/2013 | | Advanced Cell Technology Announces Settlement of Litigation |
|
| 1/8/2013 | | Advanced Cell Technology Achieves Clinical Milestone |
|
| 1/7/2013 | | Advanced Cell Technology to Present at Biotech Showcase™ 2013 |
|
| 12/20/2012 | | New Scientist Magazine Selects ACT’s Induced Pluripotent Stem (iPS) Cell-Derived Human Platelet Program As One of ‘10 Ideas That Will Shape The Year’ |
|
| 12/19/2012 | | Advanced Cell Technology Elects Not to Complete Reverse Split |
|
| 12/17/2012 | | ACT Announces Completion of Higher-Dosage Cohort in European Clinical Trial for Stargardt’s Macular Dystrophy |
|
| 12/3/2012 | | Advanced Cell Technology to Participate on Panels and Host Experts Luncheon at 2012 World Stem Cell Summit |
|
| 11/28/2012 | | ACT Announces Completion of Higher-Dosage Cohort in Both U.S. Clinical Trials |
|
| 11/8/2012 | | Advanced Cell Technology Announces Interim Data from Its Three Ongoing Macular Degeneration Trials |
|
| 11/8/2012 | | Advanced Cell Technology Announces 2012 Third Quarter Results |
|
| 11/5/2012 | | Advanced Cell Technology to Announce Third Quarter Financial Results on Thursday, November 8th |
|
| 11/1/2012 | | ACT Announces Data and Safety Monitoring Board (DSMB) Approval to Complete Second Patient Cohort in Clinical Trial for Dry AMD |
|
| 10/26/2012 | | Advanced Cell Technology to Present at Stem Cell Meeting on the Mesa’s 2nd Annual Investor and Partnering Forum |
|
| 10/22/2012 | | ACT’s European Clinical Trial Advances to First Patient Treatment with Higher Dosage of Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells |
|
| 10/18/2012 | | ACT Announces Second Stargardt’s Disease Patient Treated with Higher Dosage of Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells |
|
| 10/9/2012 | | ACT Announces Approval to Treat Additional Stargardt’s Disease Patients with Higher RPE Dosage in Both U.S. and European Clinical Trials |
|
| 9/28/2012 | | New Edition of Definitive (Two-Volume) Resource in Stem Cells Released |
|
| 9/20/2012 | | Advanced Cell Technology Secures New $35 Million Funding Commitment from Lincoln Park Capital |
|
| 9/18/2012 | | ACT to Present at Terrapinn’s Stem Cells & Regenerative Medicine Congress in Boston |
|
| 9/7/2012 | | Advanced Cell Technology to Present at 14th Annual Rodman & Renshaw Global Investment Conference |
|
| 9/4/2012 | | ACT’s Chief Scientific Officer Dr. Robert Lanza to Deliver Opening Keynote Address at 4th Annual Stem Cell Symposium in Singapore |
|
| 8/27/2012 | | ACT Comments on U.S. Appeals Court’s Dismissal Ruling in Case Challenging Federal Funding of Embryonic Stem Cell Research |
|
| 8/20/2012 | | ACT Announces Scotland’s NHS Lothian as Additional Site for EU Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration |
|
| 8/8/2012 | | Advanced Cell Technology Announces 2012 Second Quarter Results |
|
| 8/2/2012 | | ACT Announces First Dry AMD Patient Treated with Higher Dosage of Embryonic Stem Cell-Derived RPE Cells |
|
| 7/31/2012 | | Advanced Cell Technology to Announce Second Quarter Financial Results on Wednesday, August 8th |
|
| 7/30/2012 | | ACT Treats 10th Patient in Embryonic Stem Cell Trials for Macular Degeneration |
|
| 7/26/2012 | | ACT Issued Broad Patent for Human RPE Cells Derived From All Types of Pluripotent Stem Cells |
|
| 7/12/2012 | | ACT Announces First Stargardt Patient Treated With Higher Dosage of Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells |
|
| 7/9/2012 | | ACT Secures Approval to Proceed with Increased RPE Dosage for Patients in Clinical Trial for Dry AMD |
|
| 7/2/2012 | | ACT Announces Second Patient with Stargardt's Disease Treated in EU Clinical Trial |
|
| 6/14/2012 | | Advanced Cell Technology to Present at the 2012 Bio International Convention and the Clinical Outlooks for Regenerative Medicine Meeting |
|
| 5/21/2012 | | Advanced Cell Technology to Present at World Stem Cells & Regenerative Medicine Congress in London |
|
| 5/8/2012 | | Advanced Cell Technology Announces 2012 First Quarter Results |
|
| 5/7/2012 | | Advanced Cell Technology to Host Conference Call to Discuss 2012 First Quarter Results and Provide Corporate Update on Wednesday, May 9th |
|
| 5/2/2012 | | ACT Announces Massachusetts Eye and Ear as Additional Site for Clinical Trial for Dry Age-Related Macular Degeneration Using Human Embryonic Stem Cell-Derived RPE Cells |
|
| 4/26/2012 | | Advanced Cell Technology Announces Webcast of Corporate Presentation at Annual Shareholders’ Meeting Today |
|
| 4/24/2012 | | ACT Announces Data and Safety Monitoring Board (DSMB) Approval to Increase RPE Dosage for Stargardt’s Disease Patients in U.S. Trial |
|
| 4/20/2012 | | ACT Announces Third Dry AMD Patient Treated in Clinical Trial |
|
| 4/16/2012 | | ACT Announces Second Patient with Dry AMD Treated in U.S. Clinical Trial with RPE Cells Derived from Embryonic Stem Cells |
|
| 4/13/2012 | | Advanced Cell Technology to Webcast 2012 Annual Shareholders’ Meeting on April 26th |
|
| 4/9/2012 | | ACT Appoints Michael Heffernan to Board of Directors |
|
| 4/4/2012 | | ACT Announces Approval of Bascom Palmer Eye Institute as Additional Site for Stem Cell Clinical Trial for dry Age-Related Macular Degeneration |
|
| 3/14/2012 | | ACT Announces Filing of Definitive Proxy |
|
| 3/13/2012 | | Advanced Cell Technology to Present at the 24th Annual ROTH Conference |
|
| 3/1/2012 | | Advanced Cell Technology Announces 2011 Financial Results |
|
| 2/29/2012 | | Advanced Cell Technology To Announce 2011 Fourth Quarter and Year-End Results on March 1st |
|
| 2/15/2012 | | ACT Announces Approval of Wills Eye Institute as Additional Site for Stem Cell Clinical Trial for Stargardt’s Disease |
|
| 2/13/2012 | | ACT Announces Third Patient with Stargardt’s Disease Treated in U.S. Clinical Trial with RPE Cells Derived from Embryonic Stem Cells |
|
| 1/30/2012 | | ACT Announces Aberdeen Royal Infirmary in Scotland as Additional Site for Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration |
|
| 1/25/2012 | | ACT Announces that Additional Patient with Stargardt’s Disease Has Undergone Embryonic Stem Cell Transplantation at UCLA’s Jules Stein Eye Institute |
|
| 1/23/2012 | | ACT Publishes First Report of Embryonic Stem Cell (ESC)-Derived Cells Transplanted Into Patients |
|
| 1/23/2012 | | ACT Announces Europe’s First Human Embryonic Stem Cell Transplant in Patient with Stargardt’s Disease |
|
| 1/17/2012 | | Leading Eye Institute to Participate in ACT's Embryonic Stem Cell Clinical Trial for Macular Degeneration |
|
| 1/9/2012 | | Advanced Cell Technology To Present in the Regenerative Medicine Insight Track at the Biotech Showcase™ 2012 in San Francisco |
|
| 12/19/2011 | | Advanced Cell Technology Responds To Investor Inquiries |
|
| 12/12/2011 | | ACT Announces Settlements and Filing of Preliminary Proxy |
|
| 12/6/2011 | | ACT Announces Two New Appointments to Board of Directors |
|
| 11/30/2011 | | Advanced Cell Technology to Present at 2011 Stem Cell Meeting on the Mesa’s Investor and Partnering Forum |
|
| 11/9/2011 | | Advanced Cell Technology Announces 2011 Third Quarter Results |
|
| 11/7/2011 | | Advanced Cell Technology to Host Conference Call on Wednesday, November 9th to Discuss 2011 Third Quarter Results and Provide Update on Clinical Activities |
|
| 10/18/2011 | | European Ruling May Not Impact Stem Cell Lines Derived Using Advanced Cell Technology's Single-Blastomere Method |
|
| 10/5/2011 | | Scientific Luminary Dr. Robert Langer Joins ACT's Board of Directors |
|
| 10/3/2011 | | ACT Chairman and CEO Gary Rabin to Present at World Stem Cell Summit |
|
| 9/28/2011 | | ACT Receives Approval from Data and Safety Monitoring Board (DSMB) to Treat Next Patients in Stem Cell Clinical Trials |
|
| 9/22/2011 | | ACT Receives Approval for First Human Embryonic Stem Cell Trial in Europe |
|
| 9/19/2011 | | ACT Secures First Patent for Generating Hemangioblast Cells to Treat a Broad Spectrum of Vascular and Hematopoietic Disorders |
|
| 9/8/2011 | | Advanced Cell Technology to Present at Two Upcoming Conferences |
|
| 8/8/2011 | | Advanced Cell Technology Announces 2011 Second Quarter Results |
|
| 8/2/2011 | | Advanced Cell Technology to Host Conference Call to Discuss 2011 Second Quarter Results and Provide Corporate Update on Monday, Aug. 8 |
|
| 7/21/2011 | | ACT Obtains Exclusive License For Hemangioblast Technology In North America |
|
| 7/14/2011 | | ACT Announces First Patients Undergo Embryonic Stem Cell Transplantation Treatment for Stargardt's Disease and Macular Degeneration at UCLA's Jules Stein Eye Institute |
|
| 6/27/2011 | | ACT Granted EU Orphan Medicinal Product Designation for hESC-Derived RPE Cells for Treatment of Stargardt's Disease |
|
| 6/21/2011 | | ACT and Roslin Cells Announce Collaboration for Storage and Distribution of Embryonic Stem Cells Using ACT's Blastomere Technology |
|
| 6/16/2011 | | ACT Announces First Patients Enrolled in Two Clinical Trials Using Embryonic Stem Cells to Treat Stargardt's Disease and Dry Age-Related Macular Degeneration |
|
| 6/3/2011 | | Advanced Cell Technology To Webcast 2011 Annual Stockholder's Meeting To be Held on Thursday, June 9th |
|
| 5/16/2011 | | ACT Announces Oregon Health & Science University As Clinical Trial Site for its Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration |
|
| 5/9/2011 | | Advanced Cell Technology Announces 2011 First Quarter Results |
|
| 5/5/2011 | | ACT Interim Chairman and CEO Gary Rabin to Present at World Stem Cells & Regenerative Medicine Congress in London |
|
| 5/2/2011 | | Advanced Cell Technology Praises Federal Appeals Court Ruling Allowing for Continued Federal Funding of Embryonic Stem Cell Research |
|
| 4/28/2011 | | ACT Announces UCLA Institutional Review Board (IRB) Approval of its Phase 1/2 Clinical Trials using hESC-Derived RPE Cells for the Treatment of Macular Degeneration |
|
| 4/26/2011 | | ACT's Chief Scientific Officer Robert Lanza, M.D., to Deliver Speech at 3rd International Collaborative Symposium on Stem Cell Research in Seoul, South Korea |
|
| 4/20/2011 | | ACT Files European Clinical Trial Application for Phase 1/2 Study Using Embryonic Stem Cells to Treat Macular Degeneration |
|
| 3/23/2011 | | ACT to Be Issued Broad Patent for Human ES Cell-derived RPE Cells in China |
|
| 3/21/2011 | | Advanced Cell Technology Announces 2010 Results |
|
| 3/17/2011 | | Advanced Cell Technology to Host Conference Call to Discuss 2010 Year-end Financial Results and Provide Corporate Update on Monday, March 21st |
|
| 3/14/2011 | | ACT Interim Chairman and CEO Gary Rabin to Present at BIO-Europe Spring 2011 Conference |
|
| 3/10/2011 | | ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardt’s Disease |
|
| 3/9/2011 | | Advanced Cell Technology Comments on Recent Trading |
|
| 2/23/2011 | | ACT Secures Patent to Generate Embryonic Stem Cells Without Embryo Destruction |
|
| 1/12/2011 | | Advanced Cell Technology Interim Chairman and CEO Gary Rabin to Present at OneMedForum Finance Conference in San Francisco |
|
| 1/11/2011 | | ACT’s Joint Venture SCRMI Reports in Prestigious Scientific Journal that Embryonic Stem Cells are a Potentially Unlimited Source of Functional Platelets for Transfusion |
|
| 1/3/2011 | | Advanced Cell Technology Receives FDA Clearance For Clinical Trials Using Embryonic Stem Cells to Treat Age-Related Macular Degeneration |
|
| 12/31/2010 | | Advanced Cell Technology Secures $25 Million Funding Commitment |
|
| 12/27/2010 | | Advanced Cell Technology and The Roslin Institute Announce Agreement for Storage and Distribution of Embryonic Stem Cells Using ACT’s Blastomere Technology |
|
| 12/14/2010 | | Advanced Cell Technology Mourns the Passing of its Chairman and CEO William M. Caldwell IV |
|
| 12/2/2010 | | Advanced Cell Technology Strengthens Balance Sheet |
|
| 11/22/2010 | | Advanced Cell Technology Receives FDA Clearance For the First Clinical Trial Using Embryonic Stem Cells to Treat Macular Degeneration |
|
| 11/2/2010 | | Advanced Cell Technology Receives Federal Grant for Nearly $1 Million |
|
| 10/14/2010 | | Advanced Cell Technology To Present Today at 18th Annual BioPartnering Europe Conference |
|
| 9/22/2010 | | NIH Awards Dr. Robert Lanza of ACT and Dr. Kwang-Soo Kim of Harvard and McLean Hospital With Director’s Opportunity Award |
|
| 9/10/2010 | | Advanced Cell Technology to Present at the 12th Annual Rodman & Renshaw Global Investment Conference |
|
| 8/30/2010 | | Advanced Cell Technology’s Robust Cell Reprogramming/Transdifferentiation Platform Well Positioned To Capitalize on Emerging Trends in Regenerative Medicine |
|
| 8/24/2010 | | ACT May Be Uniquely Positioned as One of Few Sources of ES cells That Could Qualify for Federal Funding Under Federal Court Ruling |
|
| 8/16/2010 | | ACT Poised to Obtain and Control Key Patents to Generating iPS Cells |
|
| 7/27/2010 | | ACT Files Documentation With FDA for Clinical Trials Using ES Cells to Treat Eye Disease |
|
| 6/16/2010 | | Advanced Cell Technology Awarded Broad Patent For Production of Retinal Pigment Epithelial Cells |
|
| 6/11/2010 | | NIH Approves Advanced Cell Technology's Stem Cell Line for Federal Funding |
|
| 5/25/2010 | | Advanced Cell Technology to Present at the 11th Annual B. Riley & Co. Investor Conference in Santa Monica, California |
|
| 5/12/2010 | | Advanced Cell Technology's CEO William M. Caldwell, IV to Present at Two European Healthcare Conferences |
|
| 5/10/2010 | | Advanced Cell Technology’s Chief Scientific Officer Dr. Robert Lanza Honored By BioWorld Magazine As Leader Who Could Shape Biotech Over Next 20 Years |
|
| 4/23/2010 | | Advanced Cell Technology’s Studies to Support Phase I Multicenter Trial of Patients with Stargardt’s Macular Dystrophy Demonstrate Excellent Safety Profile |
|
| 4/5/2010 | | Advanced Cell Technology's Dr. Robert Lanza to Give Plenary, Keynote Address at the Translational Regenerative Medicine Forum |
|
| 3/17/2010 | | Advanced Cell Technology Announces Year-End Results |
|
| 3/10/2010 | | Advanced Cell Technology’s Chairman and CEO William M. Caldwell IV Interviewed on Bloomberg Radio’s Hays Advantage Show |
|
| 3/2/2010 | | Advanced Cell Technology‘s RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt’s Macular Dystrophy |
|
| 2/16/2010 | | Advanced Cell Technology's Research Featured in Scientific American, USA Today and Newsweek |
|
| 2/11/2010 | | Advanced Cell and Colleagues Report Therapeutic Cells Derived From iPS Cells Display Early Aging |
|
| 11/19/2009 | | Advanced Cell Technology Files IND With FDA For First Human Clinical Trial Using Embryonic Stem Cells to Treat Eye Disease |
|
| 9/22/2009 | | Advanced Cell Completing Pre-Clinical Activities in Preparation for IND Filing |
|
| 9/21/2009 | | Dr. Robert Lanza Featured on Michio Kaku's 'Explorations in Science' |
|
| 8/27/2009 | | Edmund Mickunas Named Vice President of Regulatory for Advanced Cell Technologies |
|
| 8/27/2009 | | Dr. Robert Lanza is Featured Guest on Deepak Chopra's SIRIUS XM Stars Radio Show |
|
| 7/21/2009 | | Advanced Cell Technology Files 2009 First Quarter 10-Q To Become Current in Financial Statements |
|
| 6/24/2009 | | Advanced Cell Technology and Collaborators at The Casey Eye Institute Present Promising Data Supporting Safety and Efficacy of Stem Cell Therapy to Combat Retinal Disease |
|
| 5/20/2009 | | Advanced Cell Technology Provides Single Blastomere Technology To CHA Bio & Diostech Co., Ltd. |
|
| 5/20/2009 | | Advanced Cell Technology Files Form 10-Q for its 2008 Second and Third Quarters |
|
| 2/2/2009 | | Cloned Human Embryos Successfully Reprogrammed Using Human −But Not Animal− Eggs |
|
| 1/5/2009 | | Functional Vasculature Generated From Advanced Cell Technologys Human Embryonic Stem Cells |
|
| 12/30/2008 | | Joint Venture Between CHA Biotech and Advanced Cell Technology to be called Stem Cell & Regenerative Medicine International |
|
| 12/18/2008 | | Advanced Cell Technology Licenses Non-Core Technology for $2.5 Million |
|
| 12/17/2008 | | Advanced Cell Technologys Technology Platform Positioned To Receive Federal Funding |
|
| 12/1/2008 | | Leading Korean Biotech Company & Advanced Cell Technology Form JV |
|
| 11/17/2008 | | Advanced Cell Technology Comments on Technology Platform |
|
| 8/30/2008 | | Advanced Cell Technology, Inc. Increases Funding Commitment to $1 Million |
|
| 8/20/2008 | | Clinical-Scale Generation of Functional Red Blood Cells from Human Embryonic Stem Cells |
|
| 4/10/2008 | | Advanced Cell Technology's Executive Invited to Present Today to FDA Advisory Committee on Cellular Tissue Therapies |
|
| 4/3/2008 | | Advanced Cell Technology Platform Yields Over 140 Cell Types from Human Embryonic Stem Cells |
|
| 4/2/2008 | | Barbara Walters' ABC Network Television Special Highlights Role that Advanced Cell Technology's Embryonic Stem Cells Play in Preventing Aging |
|
| 4/1/2008 | | Advanced Cell Technology to be Featured Tonight on ABC Television's Special Report ''Live to 150, Can You Do It? Secrets to Living Longer'' |
|
| 3/12/2008 | | Advanced Cell Technology and Catholic Healthcare West Sign Clinical Agreement |
|
| 3/5/2008 | | Advanced Cell Technology Announces Catheter Supply Agreement with Biologics Delivery Systems Group |
|
| 2/29/2008 | | Advanced Cell Technology, Inc. Enters into License Agreement with Pharming Group N.V. |
|
| 2/21/2008 | | Advanced Cell Technology Demonstrates Efficient Generation of Functional Hepatocytes (Liver cells) From Human Embryonic Stem Cells |
|
| 2/11/2008 | | Advanced Cell Technology Announces Presentation of Results from Myoblast Study at ISCTR World Symposium |
|
| 2/1/2008 | | Advanced Cell Technology Announces Completion of Pre-IND Meeting with the FDA for RPE Therapy for the Treatment of Retinal Degenerative Disease |
|
| 1/10/2008 | | Advanced Cell Technology Announces Creation of Human Embryonic Stem Cell Lines Without the Destruction of Embryos |
|
| 1/8/2008 | | Advanced Cell Technology Awarded Grant from the NIH |
|
| 12/19/2007 | | Advanced Cell Technology Issues Letter to Investors |
|
| 12/6/2007 | | Advanced Cell Technology Seeking International Partners for Its Therapeutic Programs |
|
| 11/7/2007 | | Advanced Cell Technology Announces 12-Month Results of Myoblast Therapy Trial |
|
| 11/7/2007 | | CHW Researcher Presents Results of ACT-Sponsored Trial Demonstrating Efficacy of ACT Myoblast Therapy for Heart Failure at AHA Meeting |
|
| 11/6/2007 | | Advanced Cell Technology's Chief Scientific Officer Featured Speaker at American College of Rheumatology/ Association of Rheumatology Health Professionals |
|
| 11/5/2007 | | Advanced Cell Technology and the Casey Eye Institute at Oregon Health & Science University Present Results of Functional Studies for RPE Program at Neuroscience 2007 |
|
| 11/2/2007 | | Advanced Cell Technology Announces Executive Promotions |
|
| 11/1/2007 | | Advanced Cell Technology to Present at The Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th |
|
| 10/31/2007 | | Advanced Cell Technology's Chief Scientific Officer Delivers Keynote Address at Leading International Stem Cell Conference |
|
| 10/25/2007 | | Advanced Cell Presents Phase I (b) Data Demonstrating Safety and Optimal Dosage for Myoblast Program at TCT Conference and Exposition |
|
| 10/16/2007 | | ACT's Myoblast Trial Selected as Late Breaking Trial for AHA Conference |
|
| 10/11/2007 | | Advanced Cell Technology Announces the Promotion of Dr. Robert Lanza to Chief Scientific Officer |
|
| 9/24/2007 | | Advanced Cell Technology Completes Acquisition of Mytogen, Inc. |
|
| 9/20/2007 | | NIH Announces Advanced Cell Technology's 'Single Cell Embryo Biopsy Technique' as a Means to Derive Embryonic Stem Cells to be Considered for Federal Funding |
|
| 9/4/2007 | | Advanced Cell Technology Completes $10 Million Private Placement |
|
| 8/21/2007 | | Advanced Cell Technology’s Dr. Robert Lanza Makes List of ''100 Most Inspiring People in the Life-Sciences Industry'' |
|
| 8/2/2007 | | Advanced Cell Technology Enters Into Definitive Merger Agreement With Mytogen, Inc. |
|
| 7/2/2007 | | Advanced Cell Technology Applauds Inclusion of Stem Cell Provision In $152 Billion Federal Funding Measure |
|
| 6/28/2007 | | Registration Statement for Equity Related to Advanced Cell Technology’s September 2006 PIPE Becomes Effective |
|
| 6/21/2007 | | Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo |
|
| 6/21/2007 | | Advanced Cell Technology Announces Critical Advancements in its RPE Program for the Treatment of Macular Degeneration and Other Retinal Degenerative Diseases |
|
| 6/13/2007 | | Advanced Cell Technology's VP of Research & Scientific Development, Dr. Robert Lanza, to Deliver Opening Keynote Address at Termis NA 2007 Conference on Regenerative Medicine |
|
| 6/4/2007 | | Advanced Cell Technology to Host Conference Call and Webcast to Discuss Recent Developments and Planned Acquisition of Mytogen |
|
| 5/31/2007 | | Advanced Cell Technology Enters Into Letter of Intent to Acquire Mytogen, Inc. and Proceed with the Human Clinical Trials Utilizing Myoblasts for the Treatment of Heart Failure |
|
| 5/9/2007 | | Advanced Cell Technology’s CEO to Present at Rodman & Renshaw 4th Annual Global Healthcare Conference |
|
| 5/9/2007 | | Advanced Cell Technology's Vice President of Research & Scientific Development to Present at the Life Science Institute's Symposium on Wednesday, May 9, 2007 |
|
| 5/7/2007 | | Precursor Cells Generated From Human Embryonic Stem Cells Show Ability to Repair Vascular Damage in Animals |
|
| 5/2/2007 | | Advanced Cell Technology and Wisconsin Alumni Research Foundation Announce Commercial License Agreement |
|
| 4/27/2007 | | Advanced Cell Technology’s General Counsel, Jonathan F. Atzen, Interviewed on Bloomberg Television |
|
| 4/20/2007 | | Advanced Cell Technology’s Chairman and CEO, William M. Caldwell, IV, to Present at EQUITIES 56th Anniversary Spring Conference 2007 |
|
| 3/23/2007 | | Advanced Cell’s Michael D. West, Ph.D., To Speak at 3rd Annual Stem Cell Research and Therapeutics Summit on “Strategies for the Accelerated Development of Therapeutics from hES Cells” |
|
| 3/20/2007 | | Advanced Cell Technology hESC lines to be used in CIRM-Funded Study To Test Development of New Therapies For Heart Disease |
|
| 3/12/2007 | | Advanced Cell Technology Executives to Discuss “The Business of Stem Cells” and Participate in “Conversations with Experts” at The Stem Cell Meeting Hosted by Burrill and Company at UCSF |
|
| 3/5/2007 | | Advanced Cell Technology’s Ability to Rescue Vision in Blind Rats Noted in Scientific American |
|
| 2/28/2007 | | Advanced Cell Applauds $3 Billion Stem Cell Research Program, Proposition 71, Upheld Monday By A California Appeals Court |
|
| 2/13/2007 | | Advanced Cell’s Michael West, Ph.D., Highlights ACTCellerate Platform, A Means of Accelerating the Differentiation of Cells from Human Embryonic Stem Cells, at 2nd Annual Stem Cell Summit |
|
| 2/12/2007 | | Advanced Cell Technology Names Noted Biotech Industry Executive Dr. Pedro Huertas, as Chief Development Officer to Manage the Clinical Development and Regulatory Approval Process for its Stem Cell-Based Therapeutic Products |
|
| 2/8/2007 | | Advanced Cell Technology Acquires Intellectual Property Assets of Infigen, Inc. |
|
| 2/6/2007 | | Advanced Cell Technology Announces Collaboration with the Casey Eye Institute at Oregon Health and Science University |
|
| 2/2/2007 | | Advanced Cell Technology Senior Scientist Dr. Robert Lanza Awarded for Outstanding Contributions to Biology by Brown University Biotech Group |
|
| 1/23/2007 | | Advanced Cell Technology Engages Burrill & Company to Act as Financial Advisor to Accelerate Formation of New Strategic Partnerships |
|
| 1/16/2007 | | Advanced Cell Technology Awarded Federal Grant from National Institutes of Health to Accelerate Embryonic Stem Cell Research |
|
| 1/11/2007 | | Advanced Cell Technology CEO Interviewed On CNBC’s “Power Lunch” |
|
| 1/5/2007 | | Advanced Cell Technology’s William Caldwell Interviewed By Bloomberg Television |
|
| 12/14/2006 | | Advanced Cell Technology Invited to Deliver Keynote Address at Prestigious International Stem Cell Therapy and Regenerative Medicine Conference in London |
|
| 12/11/2006 | | Advanced Cell Technology Executives to Present Keynote Address and Company Presentation at New York Society of Security Analysts (NYSSA) Conference |
|
| 12/7/2006 | | Advanced Cell Technology’s Robert Lanza, M.D., to Deliver Keynote Address at the University of Florida’s Vision Research Symposium on December 7, 2006 |
|
| 11/9/2006 | | Advanced Cell Technology Names Current Chief Executive Officer William Caldwell as Chairman of the Board |
|
| 11/7/2006 | | Advanced Cell Technology Scientist Dr. Robert Lanza Invited to Address The National Academy of Sciences at Stem Cell Policy Meeting |
|
| 11/6/2006 | | Advanced Cell Technology to Present at the 2006 PIPES Conference on November 7th |
|
| 11/6/2006 | | Advanced Cell Technology to Present Stem Cell Programs at Rodman & Renshaw’s Annual Healthcare Conference in New York |
|
| 10/19/2006 | | Advanced Cell Technology To Present Progress Report on Product Development and ACTCellerate Platform at 2006 BIO Investor Forum |
|
| 10/16/2006 | | Advanced Cell Technology’s Dr. Robert Lanza Will Be a Featured Speaker at the 6th Annual Stem Cells & Regenerative Medicine Meeting |
|
| 9/21/2006 | | Advanced Cell Technology Reports Visual Function Rescue in Animals Utilizing Human Embryonic Stem Cell-Derived Retinal Cells |
|
| 9/12/2006 | | WiCell Research Institute and Advanced Cell Technology Offer to Distribute New Stem Cell Lines to U.S. Researchers |
|
| 9/6/2006 | | Advanced Cell Technology’s Dr. Robert Lanza Testifies Before U.S. Senate Subcommittee |
|
| 9/6/2006 | | Chairman of Advanced Cell Technology’s Ethics Advisory Board Testifies Before U.S. Senate Subcommittee |
|
| 9/6/2006 | | Advanced Cell Technology Announces Settlement of Patent Interference Action |
|
| 8/23/2006 | | Advanced Cell Technology Announces Technique to Generate Human Embryonic Stem Cells that Maintains Developmental Potential of Embryo |
|
| 8/22/2006 | | Advanced Cell Technology Announces Proposed Financing |
|
| 7/25/2006 | | Advanced Cell Technology to Participate at the CIRM’s Roundtable Discussion on Industry & Stem Cells in California |
|
| 7/21/2006 | | Advanced Cell Technology Applauds Governor Schwarzenegger for Directing $150 Million Loan to Fund Stem Cell Research |
|
| 7/19/2006 | | Advanced Cell Technology Applauds Senate for Bipartisan Support of Stem Cell Legislation; Urges President Bush to fully support embryonic stem cell research |
|
| 7/17/2006 | | Advanced Cell Technology Announces Support of Federal Stem Cell Legislation Favorable to the Field of Regenerative Medicine |
|
| 7/11/2006 | | Dr. Robert Lanza of Advanced Cell Technology, Inc. and his colleagues receive praise for ''Essentials of Stem Cell Biology'' from The New England Journal of Medicine and Others |
|
| 6/9/2006 | | Advanced Cell Technology to Participate at the Marcus Evans ''Facing Stem Cell Research Challenges'' Conference, June 8-9, 2006 |
|
| 6/6/2006 | | Advanced Cell Technology Unveils ACTCellerate Technology Platform at the European Stem Cells & Regenerative Medicine Congress 2006 |
|
| 5/15/2006 | | Advanced Cell Technology Announces IND Timetables for Key Therapeutic Programs |
|
| 5/12/2006 | | Advanced Cell Technology Announces Cross License of Key Intellectual Property with Kirin |
|
| 5/11/2006 | | Advanced Cell Technology to Present at the Rodman & Renshaw 3rd Annual Global Healthcare Conference |
|
| 5/8/2006 | | Advanced Cell Technology Announces Formation of Institutional Review Board and Commencement of SCNT Program |
|
| 4/27/2006 | | Advanced Cell Technology Announces Collaboration with Xgene Corporation to Assess Its Dermal Cell Technologies in Human Skin Models |
|
| 4/18/2006 | | Advanced Cell Technology Announces Completion of Its First GMP Laboratory |
|
| 4/4/2006 | | Advanced Cell Technology Announces Exclusive License of Key Intellectual Property Portfolio on Somatic Cell Reprogramming Technology |
|
| 3/10/2006 | | Advanced Cell Technology to Participate at The Stem Cell Meeting |
|
| 3/6/2006 | | Advanced Cell Technology to Participate in the 1st International Conference on Cell Therapy and Regenerative Medicine |
|
| 2/28/2006 | | Advanced Cell Technology Formally Moves Headquarters and Opens Research Facility in California |
|
| 2/24/2006 | | Advanced Cell Technology to Participate in Medtech Insight Conference |
|
| 2/22/2006 | | Crystal Research Associates, LLC Issues Executive Informational Overview® (EIO®) on Advanced Cell Technology |
|
| 2/16/2006 | | Advanced Cell Technology to Participate in the Wharton Health Care Business Conference |
|
| 2/10/2006 | | Advanced Cell Technology to Participate in the BIO CEO & Investor Conference 2006 |
|
| 2/9/2006 | | Leading Stem Cell Company Launches Research Facility in California |
|
| 1/17/2006 | | Comprehensive New Book on Stem Cells Co-Edited by Advanced Cell Technology’s Dr. Robert Lanza |
|
| 12/8/2005 | | Advanced Cell Technology to Present at the Harris Nesbitt Focus on Healthcare Conference on December 8th |
|
| 11/23/2005 | | Scientists Allege U.S. Losing Lead in Stem Cell Research |
|
| 11/21/2005 | | Advanced Cell Technology Appoints Two New Members to it's Board of Directors |
|
| 11/8/2005 | | Robert Lanza, M.D., to Present at IBC Life Sciences’ Stem Cell Research Challenges Conference |
|
| 11/7/2005 | | Advanced Cell Technology’s Chief Scientific Officer Michael West, Ph.D. to be Featured Guest Speaker at Rodman & Renshaw Techvest 7th Annual Healthcare Conference |
|
| 10/27/2005 | | Executive Team of Advanced Cell Technology, Inc. to Present
at the PIPEs Conference 2005 in New York |
|
| 10/25/2005 | | Executive Team of Advanced Cell Technology, Inc. to Present at the C.E Unterberg Towbin Life Sciences Conference in New York |
|
| 10/20/2005 | | Michael West, PhD, President and Chief Scientific Officer of Advanced Cell Technology, Inc. to Deliver Keynote Address at the University of Toronto’s “Challenges in Regenerative Medicine” Conference |
|
| 10/16/2005 | | Advanced Cell Technology Announces Alternative Approach for Derivation
of Embryonic Stem Cell Lines |
|
| 10/10/2005 | | C.E. Unterberg Towbin Conference Presentation |
|
| 9/16/2005 | | Advanced Cell Technology Raises $17.75 Million through Private Placement of Convertible Notes and Warrants |
|
| 9/9/2005 | | Advanced Cell Technology to Deliver the Keynote Address at the Strategies for Engineered Negligible Senescence (SENS) Conference |
|
| 8/10/2005 | | Robert Lanza, M.D. to Deliver a Keynote Presentation at the Biotechniques Live! / Drug Discovery Technology & Development World Congress’ Annual Conference |
|
| 8/5/2005 | | Advanced Cell Technology Announces New Board Member |
|
| 7/27/2005 | | Advanced Cell Technology and The Burnham Institute Announce Collaboration to Isolate Stem Cell-Specific Differentiation Markers |
|
| 7/12/2005 | | Dr. Robert Lanza of Advanced Cell Technology Testifies Before Senate Subcommittee |
|
| 7/11/2005 | | Dr. Robert Lanza Of Advanced Cell Technology To Testify Before Senate Subcommittee |
|
| 6/29/2005 | | Somatic Cell Nuclear Transfer Gives Old Animals Youthful Immune Cells |
|
| 6/22/2005 | | A.C.T. Holdings, Inc. Announces Name Change to Advanced Cell Technology, Inc. |
|
| 6/17/2005 | | Advanced Cell Technology Expands Senior Scientific Team into California |
|
| 5/26/2005 | | Advanced Cell Technology Expands Senior Research Team |
|
| 5/24/2005 | | Advanced Cell Technology Reports 2005 First Quarter Results and Highlights Intellectual Property Portfolio |
|
| 5/19/2005 | | Advanced Cell Technology Expands Somatic Cell Nuclear Transfer (Cloning) and Cellular Reprogramming Intellectual Property Portfolio |
|
| 5/4/2005 | | Michael West, PhD, to Deliver Keynote Address at UC Berkeley’sStem Cells in Regenerative Medicine Conference |
|
| 4/20/2005 | | Advanced Cell Technology Names Jonathan F. Atzen as General Counsel |
|
| 4/18/2005 | | Advanced Cell Technology Files 8-KA with Securities and Exchange Commission |
|
| 4/11/2005 | | Michael West, PhD, to Deliver a Keynote Address at GTCbio Stem Cell Research & Therapeutics Conference |
|
| 4/4/2005 | | James Stewart Named Chief Financial Officer at Advanced Cell Technology |
|
| 3/22/2005 | | Dr. Robert Lanza of Advanced Cell Technology receives Wired Magazine’s 2005 Rave Award for Medicine |
|
| 3/8/2005 | | First Derivation Of Human Embryonic Stem Cells Without Exposure To Cell Feeders |
|
Frequently Requested Info